Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
Year: 2024
Type: article
Source: Gynecologic Oncology
Authors: Emiel A. De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, Lien Lippens, An M.T. Van Nuffel, Regina Baiden-Amissah, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Alex De Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K. Van de Vijver, Frédéric Amant, Katrien Vandecasteele, Bruno Verhasselt, Hannelore G. Denys
Institutions: Ghent University Hospital, Ghent University, Cancer Research Institute Ghent, Universitair Ziekenhuis Brussel, KU Leuven, Anticancer Fund, UCLouvain, University of Antwerp, Antwerp University Hospital, Institut Jules Bordet, VIB-KU Leuven Center for Cancer Biology, The Netherlands Cancer Institute, Centrum voor Gynaecologische Oncologie Amsterdam, Universitair Ziekenhuis Leuven, Amsterdam University Medical Centers
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4404137554